全文获取类型
收费全文 | 49847篇 |
免费 | 2643篇 |
国内免费 | 1933篇 |
专业分类
耳鼻咽喉 | 102篇 |
儿科学 | 252篇 |
妇产科学 | 363篇 |
基础医学 | 1409篇 |
口腔科学 | 354篇 |
临床医学 | 6074篇 |
内科学 | 3860篇 |
皮肤病学 | 333篇 |
神经病学 | 491篇 |
特种医学 | 1060篇 |
外国民族医学 | 21篇 |
外科学 | 2060篇 |
综合类 | 13315篇 |
预防医学 | 4799篇 |
眼科学 | 214篇 |
药学 | 11559篇 |
129篇 | |
中国医学 | 6881篇 |
肿瘤学 | 1147篇 |
出版年
2024年 | 474篇 |
2023年 | 1568篇 |
2022年 | 1845篇 |
2021年 | 2414篇 |
2020年 | 1659篇 |
2019年 | 1535篇 |
2018年 | 812篇 |
2017年 | 1377篇 |
2016年 | 1376篇 |
2015年 | 1705篇 |
2014年 | 2415篇 |
2013年 | 2442篇 |
2012年 | 3044篇 |
2011年 | 3033篇 |
2010年 | 2850篇 |
2009年 | 2854篇 |
2008年 | 3270篇 |
2007年 | 2689篇 |
2006年 | 2478篇 |
2005年 | 2409篇 |
2004年 | 1808篇 |
2003年 | 1723篇 |
2002年 | 1363篇 |
2001年 | 1222篇 |
2000年 | 924篇 |
1999年 | 742篇 |
1998年 | 629篇 |
1997年 | 579篇 |
1996年 | 541篇 |
1995年 | 502篇 |
1994年 | 422篇 |
1993年 | 310篇 |
1992年 | 275篇 |
1991年 | 266篇 |
1990年 | 207篇 |
1989年 | 213篇 |
1988年 | 111篇 |
1987年 | 116篇 |
1986年 | 84篇 |
1985年 | 58篇 |
1984年 | 31篇 |
1983年 | 26篇 |
1982年 | 18篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1958年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 13 毫秒
81.
1临床资料
本组39例中,男28例,女11例;年龄最小28岁,最大66岁;病程最短5d,最长3a。
2治疗方法
2.1药物组成川乌500g,草乌500g,青风藤500g,乳香500g,没药500g。 相似文献
82.
《临床合理用药杂志》2009,(5):7-7
Clavis制药公司在晚期急性髓系白血病患者中进行二期临床试验,他们宣布艾西拉滨(CP-4055)第二次中期分析结果阳性。独立的数据监察委员会对来自加个患者的临时数据分析进行评估,审查报告确认了首次由20个患者得出的阳性结果。做为二期临床试验的一部分,晚期髓系白血病患者(难治疗组)接受了三线治疗,也称为第二次抢救治疗。因为没有一个标准疗法, 相似文献
83.
84.
二甲双胍对老年2型糖尿病患者的疗效及安全性 总被引:1,自引:1,他引:0
目的:观察二甲双胍对老年2型糖尿病患者的疗效与安全性。方法:42例老年2型糖尿病患者服用磺脲类降糖药物效果不佳时加服二甲双胍治疗,在随访24周的过程中,监测空腹血糖、糖化血红蛋白、胰岛素、血乳酸及血脂,并观察药物的副作用。结果:治疗后4周空腹血糖(7.6±1.9)mmol/Lvs(9.8±2.2)mmol/L,P<0.01、糖化血红蛋白(11.3±2.6)%vs(13.6±2.5)%,P<0.01显著下降;服药12周后LDL(2.3±0.8)mmol/Lvs(2.8±0.9)mmol/L,P<0.01、TG(3.0±1.1)mmol/Lvs(3.6±1.2)mmol/L,P<0.01显著下降;服药24周HDL升高(0.89±0.08)mmol/Lvs(0.85±0.08)mmol/L,P<0.01,但血胰岛素(16.7±3.6)mmol/Lvs(18.2±4.1)mmol/L,P>0.05、血乳酸(1.6±0.5)mmol/Lvs(1.4±0.5)mmol/L,P>0.05无显著变化。23.8%患者服用二甲双胍后出现恶心与腹泻,但症状轻微且短暂。结论:二甲双胍是治疗老年2型糖尿病患者安全、有效的药物。 相似文献
85.
86.
87.
Weijiang Zhao Fang Yuan Guilin Li Zhongfang Shi Yun Cui Yazhuo Zhang Zhongcheng Wang 《中国神经再生研究》2007,2(5):276-280
BACKGROUND: During formation of prolactin neoplasia, how cells and its structure in adenohypophysis affect prolactin cells should be further studied. Intermediate lobe can be regarded as a driving region to release prolactin (PRL) and may promote formation of prolactin neoplasia in pituitary anterior lobe.
OBJECTIVE: To observe the effect of diethylstilbestrol (DES) on the expressions of μ and m-calpains in pituitary intermediate lobe of female Wistar rats.
DESIGN: Observational contrast animal study.
SETTING: Beijing Neurosurgical Institute.
MATERIALS: A total of 21 female Wistar rats, 3 weeks old weighing 70–80 g were housed with free access to tap water and standard pellet food. They were kept in a CL-grade condition, at (24±1)℃ and a humidity of (55±5)%, and with a 12 hours day-night cycle. Caprine anti-μ- and m-calpains antibodies were provided by Santa Cruz Biotechnology, CA, USA; rabbit-anti-PRL antibodies by Dako, Denmark; rabbit-anti-ACTH antibody by Boster Company, Wuhan.
METHODS: The experiment was carried out in Pathophysiological Department and Animal Laboratory, Beijing Neurosurgical Institute from August 2006 to January 2007. ① Rats were randomly divided into groups with 7 in each group, including vehicle control group, in which rats were injected intraperitoneally with sun-flower seed oil (1 mL/kg, twice a week) for 16 weeks; DES group, where animals were administered with DES (5 mg/kg, twice a week) for 16 weeks; DES + vehicle control group, in which DES was administered for 12 weeks at the same dose with those in DES group, and then was discontinued and replaced by sun-flower seed oil (1 mL/kg, twice a week) for the following 4 weeks. ② At 16 weeks later, pituitary tissue was dealt with HE staining and PRL immunohistochemical examination to observe evoke of tumor; meanwhile, immunohistochemical examination was used to observe expression of PRL of pituitary anterior lobe, expressions of μ- and m-calpains of pituitary intermediate lobe and distribution of adrenocorticotropin.
MAIN OUTCOME MEASURES: ① Expression of PRL of pituitary anterior lobe, expressions of μ- and m-calpains of pituitary intermediate lobe and distribution of adrenocorticotropin. ② Morphological observation of pituitary tissue.
RESULTS: All 21 rats were involved in the final analysis. ① Results of immunohistochemical examination: Morphological changes of neoplasia in DES group were strongly positive to PRL, and this suggested that formation of prolactin adenoma was observed in pituitary tissue. As compared with vehicle control group, expression of adrenoeorticotropic hormone (ACTH) was increased in both DES group and DES + vehicle control group. In addition, expressions of μ- and m-calpains in pituitary intermediate lobe were higher in DES group than that in vehicle control group. Otherwise, expressions of m-calpains in pituitary intermediate lobe was decreased in DES + vehicle control group, but expression of μ-calpains was still increased. ② Morphological observation of pituitary tissue: Gland tubes were orderly arranged in rats in vehicle control group. Anterior pituitary gland in rats of DES group demonstrated an apparent disappearance of gland tubes and a relatively large-scaled vasculature formation, namely the vascular lake lined by tightly arranged endothelial cells. Local integrated tumor cell arrangements were also detected. In addition, the border between the IL and the anterior lobe was locally blurred. The definite tumor-like changes in pituitary tissues were confirmed in 6 of 7 female Wistar rats in DES group, and one spontaneous occurrence of tumor formation was found in vehicle control group. In DES + vehicle control group, DES withdrawal led to the subtile emergence of gland tube cavity, although tumor-like cells still existed in 4 of 7 rats, suggesting occurrence of the tumor regression due to the withdrawal of DES.
CONCLUSION: A long-term application of DES can enhance the expressions of ubiquitours neutral cysteine protease in pituitary intermediate lobe and this suggests that both of them play a key role in release of hormone and formation of prolactin neoplasia through directly promoting PRL expression and release of neighboring pituitary intermediate lobe. 相似文献
88.
赵健康 《中国实用乡村医生杂志》2009,16(4)
糖耐量减低是正常糖代谢与糖尿病之间的中间代谢状态,是发展为糖尿病和心血管疾病的重要危险因素之一[1,2]。因此,积极干预治疗糖耐量减低对于预防糖尿病和心血管疾病的发生具有十分重要的意义。 相似文献
89.
刘永岗 《延安大学学报(医学科学版)》2009,7(4)
目的 对二甲双胍的应用提供临床依据.方法 查阅国内外近几年的研究和相关文献资料.结果 二甲双胍能减少IGT患者糖尿病的发生率,明显降低T2DM的血糖,并因不良反应少,而使患者有良好的依从性.结论 早期应用二甲双胍治疗是必要和可行的措施. 相似文献
90.
小柴胡汤加减治疗消化性溃疡80例 总被引:1,自引:0,他引:1
自2003年3月~2006年3月,笔者应用小柴胡汤加减治疗消化性溃疡患者80例,临床上取得满意的疗效,现报告如下。1临床资料1.1一般资料本组80例病例经电子胃镜检查确诊为消化性溃疡并同时行幽门螺旋杆菌(Hp)培养为阳性。80例中男45例,女35例;年龄22岁~60岁.其中,30~50岁占总数的70%;病程0.5~1a。 相似文献